Conference abstractPublished 8 May 2017
T-type calcium channel blocker, KCP10043F inhibits G1 cell cycle phase and induces apoptosis in caspasedependent pathway on lung adenocarcinoma
Department of Life and Nonopharmaceutical Sciences, College of Pharmacy, Kyung Hee University, South Korea
Abstract
KCP10043F (3,4-dihydroquinazoline derivative) is a selective T-type Ca2+ channel blockers and other studies showed that selective Ca2+ channel bloackers could inhibit the growth of cancer cells such as ovarian, lung, and pancreatic cancer cells. we now investigated that KCP10043F induced G1 arrest dose-dependently and cyclins and CDKs are regulated at protein expression level. In addition, KCP10043F made synergic effect on cell death with Etoposide, a novel anti-cancer agent. Then we continuously studied that KCP10043F induced apoptosis at high dose, detected by Annexin V-FITC / PI staining assay, and this cell death was dependent on caspase-activation, both capsase-3, 8 and -9. moreover, Bcl-2(anti-apoptotic protein), was down-regulated and Bax(pro-apoptotic protein) was up-regulated by this agent. This pathway was confirmed by using z-VAD-FMK, pan-caspase inhibitor, blocked the cell death induced by KCP10043F. Co-treatment with etoposide in low-dose also activated caspase-8,9. So our results suggested pathway how KCP10043F makes synergic effect on A549 cell line and it has possibility to be a potential anti-cancer agent reducing chemoresistance of lung cancers that show the lowest viability among many cancers.
Subjects
Pharmaceutical SciencesFollow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jeong hun Lee”
- BylineArticles whose byline prints “Dong Gyu Leem”
- BylineArticles whose byline prints “Dong Hyun Shin”
- BylineArticles whose byline prints “Ji Sun Shin”
- BylineArticles whose byline prints “Kyung-Tae Lee”
